Category Archives: Europe

First 'Real' European Patent Imminent

By Guest Blogger | Published: May 8, 2013
It’s exciting times for patents in Europe. Not everyone’s excitement is pleasurable, but there’s certainly plenty going on, writes Reflector, Pharm Exec’s EU correspondent. Much of the excitement is linked to the imminent advent of Europe’s first real European patent. After decades of failed attempts, by the beginning of 2014 the European Union will finally have [...]
Also posted in Guest Blog, IP | Tagged , , , , , | 1 Comment

Catch On to Content Marketing

By Guest Blogger | Published: May 7, 2013
Pharma should have a head start in the content marketing race, but familiar fears are holding it back, writes Peter Houston. You know this: digital marketing means you have the potential to get your message in front of more people than ever before; search and social media offer reach on an unparalleled scale. According to global [...]
Also posted in Global, Guest Blog, Marketing, Op-Ed | Leave a comment

Measles Outbreak in UK: Why We Need to Maintain a Balance of Communication Power

By Guest Blogger | Published: April 22, 2013
The current UK measles outbreak reminds us that, as far as healthcare communication is concerned, the voice of the people is not necessarily the voice of God, writes Reflector. The localized outbreak of measles in the UK is alarming in more ways than one. There can only be sympathy for the victims of this sudden return [...]
Also posted in Global, Guest Blog, Patient Communication, Technology, healthcare, patient education, social media | Tagged , , | Leave a comment

Tough Times Ahead for New Medicines under NHS England?

By Guest Blogger | Published: April 22, 2013
By Leela Barham You’d be forgiven for missing it with the vast array of new agencies and the policy documents, guidance, consultations and ‘engagement’ activity they’re doing on in the ‘new’ NHS in England, but on the 4th April NHS England (formerly the NHS Commissioning Board) set out 15 commissioning policies in 250 pages.  They’re important, [...]
Also posted in Global, Guest Blog, healthcare, pricing | Tagged , , , , , | Leave a comment

England's Cancer Drug Fund: An Acid Test for Value Based Pricing

By Guest Blogger | Published: April 12, 2013
By Leela Barham. England’s Cancer Drugs Fund (CDF) could be in its final financial year, after running in full since April 2011.  The fund covers the cost of cancer treatments either when NICE has said ‘no’, or hasn’t yet come to a view.  Companies can’t circumvent NICE though; if a company was invited to submit to [...]
Also posted in Global, Guest Blog, Op-Ed, pricing | Tagged , , , , , | Leave a comment